Inflammatory Stratification in Primary Sjögren's Syndrome Reveals Novel Immune Cell Alterations in Patients' Minor Salivary Glands.
B cells
T cells
adipose tissue
antigen-presenting cells
inflammatory severity index
minor salivary glands
patient stratification
primary Sjögren’s syndrome
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
04
2021
accepted:
24
06
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
22
12
2021
Statut:
epublish
Résumé
There is a critical need to deconvolute the heterogeneity displayed by the minor salivary glands of primary Sjögren's syndrome (pSS) patients. This is challenging primarily because the disease etiology remains unknown. The hypothesis includes that initial events in the disease pathogenesis target the salivary glands, thereby triggering the development of focal infiltrates (≥50 mononuclear cells) and finally germinal center-like structures. However, the proportion of key mononuclear immune cells residing at these sites, in combination with the overall ratio of morphometric tissue atrophy and adipose infiltration within the minor salivary glands (MSG) parenchyma at distinct phases of inflammatory disease establishment and progression have not been quantified in detail. In this cross-sectional study, we intended to address this problem by stratifying 85 patients into mild (S1), moderate (S2), and severe (S3) stages using the Inflammatory severity index. We found that mild (<3%) and marked (≥3%) levels of atrophy were accompanied by the respective levels of adipose infiltration in the non-SS sicca controls (
Identifiants
pubmed: 34322130
doi: 10.3389/fimmu.2021.701581
pmc: PMC8311440
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
701581Informations de copyright
Copyright © 2021 Bharaj, Aqrawi, Fromreide, Jonsson, Brun, Appel and Skarstein.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Immunol. 2013 May;147(2):95-104
pubmed: 23578551
J Immunol. 2017 Oct 15;199(8):2745-2757
pubmed: 28904129
Arthritis Rheumatol. 2018 Sep;70(9):1481-1488
pubmed: 29669392
J Korean Med Sci. 2016 Feb;31(2):190-5
pubmed: 26839471
Int J Rheum Dis. 2017 Feb;20(2):245-251
pubmed: 28556615
Ann Rheum Dis. 2017 Jul;76(7):1161-1168
pubmed: 27965259
Arthritis Rheum. 2006 Jul;54(7):2280-8
pubmed: 16802367
Ann Rheum Dis. 2008 Jul;67(7):949-54
pubmed: 17962240
Ann Rheum Dis. 2011 Aug;70(8):1363-8
pubmed: 21715359
Lupus. 2010 Feb;19(2):138-45
pubmed: 19952070
Nat Rev Rheumatol. 2010 Sep;6(9):529-37
pubmed: 20683439
Scand J Immunol. 2018 Jun 8;:e12679
pubmed: 29882349
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Arthritis Rheum. 2006 Jul;54(7):2295-9
pubmed: 16802369
Clin Exp Rheumatol. 1998 Jan-Feb;16(1):63-5
pubmed: 9543564
Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):80-88
pubmed: 29148407
Autoimmunity. 2018 May;51(3):135-146
pubmed: 29504848
Autoimmunity. 2017 Dec;50(8):451-457
pubmed: 28988489
Sci Rep. 2017 Sep 19;7(1):11897
pubmed: 28928382
J Clin Pathol. 1986 Apr;39(4):406-17
pubmed: 3700674
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
J Oral Pathol Med. 2008 Oct;37(9):515-21
pubmed: 18662248
Rom J Morphol Embryol. 2017;58(2):409-417
pubmed: 28730224
J Rheumatol. 2007 Oct;34(10):2044-9
pubmed: 17787040
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):27-33
pubmed: 33095140
Int J Clin Exp Pathol. 2014 Apr 15;7(5):1988-96
pubmed: 24966908
Arthritis Rheum. 2011 Jul;63(7):2021-30
pubmed: 21480190
Arthritis Res Ther. 2011 Jan 07;13(1):R2
pubmed: 21214903
J Autoimmun. 2010 Jun;34(4):400-7
pubmed: 19889514
Ann Rheum Dis. 2017 Oct;76(10):1781-1784
pubmed: 28710097
J Autoimmun. 1989 Aug;2(4):553-8
pubmed: 2789657
Autoimmunity. 2016 Aug;49(5):338-46
pubmed: 27206986
J Rheumatol. 2014 Nov;41(11):2214-22
pubmed: 25274895
Rheumatology (Oxford). 2009 Sep;48(9):1102-6
pubmed: 19574472
J Rheumatol. 2013 Sep;40(9):1566-71
pubmed: 23908448
Front Immunol. 2020 Oct 19;11:594096
pubmed: 33193443